Innovative Formulation Focus LATITUDE Pharmaceuticals specializes in developing cutting-edge formulations for insoluble and unstable drug molecules, creating proprietary drug delivery technologies and license-ready formulations, which presents opportunities for collaboration on complex formulation projects.

Strategic Acquisition The company's acquisition by BioVie Inc. in 2016 indicates strong industry interest and potential access to expanded resources and client networks, opening doors for strategic partnerships and joint development initiatives.

Growth Potential With annual revenues between $10M and $25M and a specialized focus in GMP manufacturing, LATITUDE is positioned as a nimble provider capable of serving emerging biotech firms seeking innovative manufacturing solutions.

Industry Positioning Operating within a competitive sector with comparable firms like Cambrex and Vetter Pharma, LATITUDE can leverage its specialized expertise in problematic drug molecules to differentiate and attract clients needing advanced formulation services.

Market Expansion Given the increasing demand for formulation solutions for challenging drug compounds, LATITUDE has growth opportunities in expanding its client base within the biotech and pharmaceutical industries, especially by emphasizing its innovative and license-ready technologies.